Assembly Biosciences logo
Assembly Biosciences ASMB
$ 14.99 1.83%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Assembly Biosciences Balance Sheet 2011-2024 | ASMB

Annual Balance Sheet Assembly Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-17.5 M -49 M -39.2 M -49.3 M -34.5 M -41.5 M -82 M -28.6 M -27.1 M -29.1 M -27.1 M -20.5 M -37 M

Long Term Debt

1.12 M 101 K 3.32 M - - - - - - - - - -

Long Term Debt Current

1.22 M 3.36 M 3.15 M 3.4 M 3.19 M - - - - - - - -

Total Non Current Liabilities

- - - 18.2 M 42.2 M 38.9 M 42.7 M 11.1 M 11.6 M 11.6 M - - -

Total Current Liabilities

39.2 M 16.3 M 16.1 M 24.4 M 24.4 M 18.5 M 13.5 M 7.12 M 3.4 M 1.05 M 2.64 M - 2.51 M

Total Liabilities

95.7 M 19.1 M 22.1 M 42.7 M 66.7 M 57.4 M 56.2 M 18.2 M 15 M 12.7 M 2.64 M 2.75 M 2.51 M

Deferred Revenue

30.9 M - - 8.99 M 6.41 M 5.1 M 5.23 M - - - - - -

Retained Earnings

-786 M -725 M -631 M -502 M -439 M -342 M -251 M -208 M -164 M -136 M -112 M -92.3 M -67.5 M

Total Assets

137 M 102 M 191 M 283 M 340 M 268 M 169 M 98.1 M 134 M 71.2 M 27.1 M 20.6 M 37 M

Cash and Cash Equivalents

19.8 M 52.4 M 45.6 M 59.4 M 46.7 M 41.5 M 82 M 28.6 M 27.1 M 29.1 M 27.1 M 20.5 M 37 M

Book Value

41.1 M 82.7 M 169 M 241 M 273 M 211 M 113 M 79.9 M 119 M 58.6 M 24.5 M 17.8 M 34.5 M

Total Shareholders Equity

41.1 M 82.7 M 169 M 241 M 273 M 211 M 113 M 79.9 M 119 M 58.6 M 24.5 M 17.8 M 34.5 M

All numbers in USD currency

Quarterly Balance Sheet Assembly Biosciences

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

113 K 451 K 791 K 1.12 M 50 K 64 K 80 K 101 K 918 K 1.77 M 2.5 M 3.32 M 4.14 M 4.91 M 5.64 M 6.72 M 6.72 M 6.72 M 6.72 M 9.08 M 9.08 M 9.08 M 9.08 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - 38.9 M 38.9 M 40.2 M 41.5 M 42.7 M 42.7 M 42.7 M 42.7 M 11.1 M 11.1 M 11.1 M 11.1 M 11.6 M 11.6 M 11.6 M 11.6 M 11.6 M 11.6 M 11.6 M - - - - - - - - - - - - -

Total Liabilities

74.3 M 80.6 M 87.3 M 95.7 M 9.92 M 11.6 M 12.8 M 19.1 M 19.1 M 19.5 M 15.9 M 22.1 M 24.3 M 30.3 M 31.7 M 42.7 M 42.7 M 42.7 M 42.7 M 66.7 M 66.7 M 66.7 M 66.7 M 57.4 M 57.4 M 57.4 M 57.4 M 56.2 M 56.2 M 56.2 M 56.2 M 18.2 M 18.2 M 18.2 M 18.2 M 15 M 15 M 15 M 15 M 12.7 M 12.7 M 12.7 M 12.7 M 2.64 M 2.64 M 2.64 M 2.64 M 2.75 M 2.75 M 2.75 M 2.75 M 2.51 M 1.18 M 2.09 M -

Deferred Revenue

32.6 M 33.1 M 32.8 M 30.9 M - - - - - - - - - - - - - - 6.72 M 6.41 M 6.41 M 6.08 M 9.93 M 5.1 M 5.11 M 5.51 M 5.1 M 5.23 M 5.23 M 5.23 M 5.23 M - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-816 M -806 M -795 M -786 M -775 M -760 M -743 M -725 M -702 M -679 M -655 M -631 M -571 M -552 M -529 M -502 M -502 M -502 M -502 M -439 M -439 M -439 M -439 M -342 M -342 M -342 M -342 M -251 M -251 M -251 M -251 M -208 M -208 M -208 M -208 M -164 M -164 M -164 M -164 M -136 M -136 M -136 M -136 M -112 M -112 M - - - - - - - - - -

Total Assets

100 M 115 M 120 M 137 M 51.6 M 66.6 M 83.1 M 102 M 122 M 143 M 163 M 191 M 249 M 262 M 279 M 283 M 283 M 283 M 283 M 340 M 340 M 340 M 340 M 268 M 268 M 268 M 268 M 169 M 169 M 169 M 169 M 98.1 M 98.1 M 98.1 M 98.1 M 134 M 134 M 134 M 134 M 71.2 M 71.2 M 71.2 M 71.2 M 27.1 M 27.1 M 27.1 M 27.1 M 20.6 M 20.6 M 20.6 M 20.6 M 37 M 37 M 37 M 37 M

Cash and Cash Equivalents

28.5 M 19.2 M 18.7 M 19.8 M 26.7 M 21.6 M 43.5 M 52.4 M 54.7 M 43.1 M 51.2 M 45.6 M 70.8 M 59.5 M 78.3 M 59.4 M 59.4 M 59.4 M 59.4 M 46.7 M 46.7 M 46.7 M 46.7 M 41.5 M 41.5 M 41.5 M 41.5 M 82 M 82 M 82 M 82 M 28.6 M 28.6 M 28.6 M 28.6 M 27.1 M 27.1 M 27.1 M 27.1 M 29.1 M 29.1 M 29.1 M 29.1 M 27.1 M 27.1 M 27.1 M 27.1 M 20.5 M 20.5 M 20.5 M 20.5 M 37 M 37 M 37 M 37 M

Book Value

26 M 34.7 M 32.6 M 41.1 M 41.7 M 54.9 M 70.3 M 82.7 M 102 M 124 M 147 M 169 M 225 M 232 M 247 M 241 M 241 M 241 M 241 M 273 M 273 M 273 M 273 M 211 M 211 M 211 M 211 M 113 M 113 M 113 M 113 M 79.9 M 79.9 M 79.9 M 79.9 M 119 M 119 M 119 M 119 M 58.6 M 58.6 M 58.6 M 58.6 M 24.5 M 24.5 M 24.5 M 24.5 M 17.8 M 17.8 M 17.8 M 17.8 M 34.5 M 35.9 M 35 M 37 M

Total Shareholders Equity

26 M 34.7 M 32.6 M 41.1 M 41.7 M 54.9 M 70.3 M 82.7 M 102 M 124 M 147 M 169 M 225 M 232 M 247 M 241 M 241 M 241 M 241 M 273 M 273 M 273 M 273 M 211 M 211 M 211 M 211 M 113 M 113 M 113 M 113 M 79.9 M 79.9 M 79.9 M 79.9 M 119 M 119 M 119 M 119 M 58.6 M 58.6 M 58.6 M 58.6 M 24.5 M 24.5 M 24.5 M 24.5 M 17.8 M 17.8 M 17.8 M 17.8 M 34.5 M 34.5 M 34.5 M 34.5 M

All numbers in USD currency